Vir Biotechnology, Inc. (VIR)
9.03
+0.15
(+1.69%)
USD |
NASDAQ |
May 21, 16:00
9.025
0.00 (0.00%)
After-Hours: 19:59
Vir Biotechnology EPS Diluted (Quarterly) : -0.853 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| BioMarin Pharmaceutical, Inc. | 0.5431 |
| Krystal Biotech, Inc. | 1.833 |
| Gossamer Bio, Inc. | -0.1993 |
| Sensei Biotherapeutics, Inc. | -3.622 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -125.70M |
| Revenue (Quarterly) | -0.029M |
| Total Expenses (Quarterly) | 125.67M |
| Enterprise Value | 1.140B |
| Earnings Yield | -34.74% |
| Normalized Earnings Yield | -33.94 |